Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1983 Feb;46(2):140–144. doi: 10.1136/jnnp.46.2.140

Speech therapy for Parkinson's disease.

S Scott, F I Caird
PMCID: PMC1027296  PMID: 6842217

Abstract

Twenty-six patients with the speech disorder of Parkinson's disease received daily speech therapy (prosodic exercises) at home for 2 to 3 weeks. There were significant improvements in speech as assessed by scores for prosodic abnormality and intelligibility' and these were maintained in part for up to 3 months. The degree of improvement was clinically and psychologically important, and relatives commented on the social benefits. The use of a visual reinforcement device produced limited benefit over and above that from prosodic exercises alone, except to patients with severe speech disorder.

Full text

PDF
140

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Leanderson R., Meyerson B. A., Persson A. Effect of L-dopa on speech in Parkinsonism. An EMG study of labial articulatory function. J Neurol Neurosurg Psychiatry. 1971 Dec;34(6):679–681. doi: 10.1136/jnnp.34.6.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Logemann J. A., Fisher H. B., Boshes B., Blonsky E. R. Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. J Speech Hear Disord. 1978 Feb;43(1):47–57. doi: 10.1044/jshd.4301.47. [DOI] [PubMed] [Google Scholar]
  3. MONRAD-KROHN G. H. Quelques remarques sur les alterations prosodiques et leurs consequences dans la clinique neurologique. Acta Psychiatr Neurol Scand Suppl. 1956;108:265–267. [PubMed] [Google Scholar]
  4. Nakano K. K., Zubick H., Tyler H. R. Speech defects of parkinsonian patients. Effects of levodopa therapy on speech intelligibility. Neurology. 1973 Aug;23(8):865–870. doi: 10.1212/wnl.23.8.865. [DOI] [PubMed] [Google Scholar]
  5. Rigrodsky S., Morrison E. B. Speech changes in parkinsonism during L-dopa therapy: preliminary findings. J Am Geriatr Soc. 1970 Feb;18(2):142–151. doi: 10.1111/j.1532-5415.1970.tb02111.x. [DOI] [PubMed] [Google Scholar]
  6. Sarno M. T. Speech impairment in Parkinson's disease. Arch Phys Med Rehabil. 1968 May;49(5):269–275. [PubMed] [Google Scholar]
  7. Scott S., Caird F. I. Speech therapy for patients with Parkinson's disease. Br Med J (Clin Res Ed) 1981 Oct 24;283(6299):1088–1088. doi: 10.1136/bmj.283.6299.1088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Uziel A., Bohe M., Cadilhac J., Passouant P. Les troubles de la voix et de la parole dans les syndromes parkinsoniens. Folia Phoniatr (Basel) 1975;27(3):166–176. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES